Rabeprazole Sodium (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Rabeprazole Sodium drug offered from Aurobindo Pharma Limited. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
NON-PROPRIETARY NAME: | Rabeprazole Sodium |
SUBSTANCE NAME: | RABEPRAZOLE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-17 |
END MARKETING DATE: | 0000-00-00 |
Rabeprazole Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Rabeprazole Sodium from Aurobindo Pharma Limited |
LABELER NAME: | Aurobindo Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2017-02-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65862-721_d11c3211-b4d4-4893-8c1c-b8fb6d0a0b89 |
PRODUCT NDC: | 65862-721 |
APPLICATION NUMBER: | ANDA205761 |
Other RABEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers: